Literature DB >> 19819462

The distinctive separation attributes of mixed-mode resins and their application in monoclonal antibody downstream purification process.

Jie Chen1, Jen Tetrault, Yanyu Zhang, Andy Wasserman, Greg Conley, Mike Dileo, Elliot Haimes, Andrew E Nixon, Arthur Ley.   

Abstract

Increased upstream productivity and the continuous pressure to deliver high quality drug product have resulted in the development of new separation technologies and platform strategies for downstream purification processes of monoclonal antibodies (mAb). In this study, the separation attributes of three mixed-mode resins, Mercapto-Ethyl-Pyridine (MEP) hydrophobic charge induction resin, Capto adhere multi-modal anion exchange resin, and ceramic hydroxyapatite/fluoroapatite (CHT/CFT) resins, were investigated to define their roles in monoclonal antibody purification processes. We demonstrated that the multi-modal nature of ligands on mixed-mode resins allows the separation resolution to be honed, either through a single dominant mechanism or through mix-modal balanced purification strategies. In addition, the three mixed-mode resins present different purification powers for different types of impurities. We also demonstrated that besides enhancing chromatography separation and improve product quality, especially for high molecular weight (HMW) aggregate reduction, mixed-mode resins can also help to improve process efficiency in industrial-scale mAb drug manufacturing. Our results underscore the importance of selecting appropriate chromatography resins during DSP design to obtain the best overall process outcome. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819462     DOI: 10.1016/j.chroma.2009.09.047

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

1.  Minibodies and Multimodal Chromatography Methods: A Convergence of Challenge and Opportunity.

Authors:  Pete Gagnon; Chia-Wei Cheung; Eric J Lepin; Anna M Wu; Mark A Sherman; Andrew A Raubitschek; Paul J Yazaki
Journal:  Bioprocess Int       Date:  2010-02

2.  Isolation and detection of a KDEL-tagged recombinant cholera toxin B subunit from Nicotiana benthamiana.

Authors:  David A Morris; Micaela A Reeves; Joshua M Royal; Krystal T Hamorsky; Nobuyuki Matoba
Journal:  Process Biochem       Date:  2020-11-04       Impact factor: 3.757

Review 3.  Preparative purification of recombinant proteins: current status and future trends.

Authors:  Mayank Saraswat; Luca Musante; Alessandra Ravidá; Brian Shortt; Barry Byrne; Harry Holthofer
Journal:  Biomed Res Int       Date:  2013-12-17       Impact factor: 3.411

4.  Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.

Authors:  Andrew D Tustian; Christine Endicott; Benjamin Adams; John Mattila; Hanne Bak
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

Review 5.  Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.

Authors:  Weihong Qu; Mingxi Wang; Yaqing Wu; Ruian Xu
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.